title: Organic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss/disease.
abstract: Skeletal health consequences associated with chronic inflammatory respiratory disease, and particularly chronic obstructive pulmonary disease (COPD), contribute to overall disease morbidity. Agricultural environmental exposures induce significant airway diseases, including COPD. However, animal models to understand inhalant exposure-induced lung injury and bone disease have not been described. Using micro-computed tomography (micro-CT) imaging technology and histology, bone quantity and quality measurements were investigated in mice after repetitive intranasal inhalation exposures to complex organic dust extracts (ODEs) from swine confinement facilities. Comparison experiments with LPS and peptidoglycan (PGN) alone were also performed. After 3 weeks of repetitive ODE inhalation exposure, significant loss of bone mineral density and trabecular bone volume fraction was evident, with altered morphological microarchitecture changes in the trabecular bone, compared with saline-treated control animals. Torsional resistance was also significantly reduced. Compared with saline treatment, ODE-treated mice demonstrated decreased collagen and proteoglycan content in their articular cartilage, according to histopathology. Significant bone deterioration was also evident after repetitive intranasal inhalant treatment with LPS and PGN. These findings were not secondary to animal distress, and not entirely dependent on the degree of induced lung parenchymal inflammation. Repetitive LPS treatment demonstrated the most pronounced changes in bone parameters, and PGN treatment resulted in the greatest lung parenchymal inflammatory changes. Collectively, repetitive inhalation exposures to noninfectious inflammatory agents such as complex organic dust, LPS, and PGN resulted in bone loss. This animal model may contribute to efforts toward understanding the mechanisms and evaluating the therapeutics associated with adverse skeletal health consequences after subchronic airway injury.
authors.affiliation: 1 Division of Rheumatology.
authors.forename: Anand
authors.initials: A
authors.lastname: Dusad
authors.forename: Geoff M
authors.initials: GM
authors.lastname: Thiele
authors.forename: Lynell W
authors.initials: LW
authors.lastname: Klassen
authors.forename: Angela M
authors.initials: AM
authors.lastname: Gleason
authors.forename: Christopher
authors.initials: C
authors.lastname: Bauer
authors.forename: Ted R
authors.initials: TR
authors.lastname: Mikuls
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Duryee
authors.forename: William W
authors.initials: WW
authors.lastname: West
authors.forename: Debra J
authors.initials: DJ
authors.lastname: Romberger
authors.forename: Jill A
authors.initials: JA
authors.lastname: Poole
mesh_terms: D000818:Animals; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000378:metabolism; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000378:metabolism; D002358:Cartilage, Articular / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D004391:Dust; D006799:Housing, Animal; D019570:Inhalation Exposure / Q000009:adverse effects*; D008070:Lipopolysaccharides / Q000633:toxicity*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009930:Organic Chemicals / Q000633:toxicity*; D010457:Peptidoglycan / Q000633:toxicity*; D011014:Pneumonia / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism; D018570:Risk Assessment; D012307:Risk Factors; D013552:Swine; D013997:Time Factors; D055114:X-Ray Microtomography
chemical_list: D004391:Dust; D008070:Lipopolysaccharides; D009930:Organic Chemicals; D010457:Peptidoglycan; D011509:Proteoglycans; D003094:Collagen